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Background: The prevalence of gestational diabetes (GDM) in low and lower middle income countries (LLMIC) is
increasing. Despite its associated short and long term complications for mothers and their newborns, there is a lack
of knowledge about how to detect and manage GDM. The objective of our study was to identify the challenges
that first line healthcare providers in LLMIC face in screening and management of GDM.
Methods: We conducted a cross-sectional survey of key informants from 40 low and lower-middle income
countries in Africa, South-Asia and Latin-America by sending out questionnaires to 182 gynecologists,
endocrinologists and medical doctors. Sixty-seven respondents from 26 LLMIC provided information on the
challenges they encounter. Data was thematically analyzed and revealed eight overarching themes, including
guidelines; human resources; access; costs; availability of services, equipment and drugs; patient and community
factors; and collaboration and communication.
Results: Unavailability of guidelines combined with lack of knowledge about GDM on the part of both providers
and patients poses a substantial barrier to detection and management of GDM, leading to deficiencies in screening
and counseling. Limited access to regular monitoring and follow-up care as a result of distance and costs, in
particular with respect to additional expenses related to specific tests and changes in diet were identified as
important challenges. Services were not available at all levels nor was adequate testing equipment. Patient factors
included lack of motivation and compliance with the recommended therapy. Respondents also highlighted the lack
of communication and collaboration between different specialists and treatment delays as a result of patients being
seen by multiple providers.
Conclusions: Providers from LLMIC face various challenges related to screening and managing GDM. Policy makers
need to address these challenges by strengthening their health care system as a whole and by assuring that non-
communicable diseases are better integrated into the existing packages of free or subsidized maternal health care.
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Global prevalence of diabetes mellitus in women of re-
productive age is steadily increasing [1]. Similarly, the
incidence of hyperglycemia diagnosed for the first time
during pregnancy is on the rise and has reached nearly
17 % worldwide [1, 2]. The proportion of women with
gestational diabetes (GDM) has not yet been assessed in
many low and lower-middle income countries (LLMIC).
However, the few studies conducted in Sub-Saharan
Africa reveal prevalence rates in pregnant women ran-
ging from 2 % to 14 % in Sub-Saharan Africa [3–5], and
up to 18 % in South Asia [6, 7].
These numbers are worrying, as GDM is associated
with a range of immediate and long term complications
for both mothers and their newborns. Babies of affected
mothers are at higher risk of being delivered preterm, of
being macrosomic or suffering from hypoglycemia, jaun-
dice or respiratory distress. Mothers have an increased
risk of developing pregnancy-induced hypertension or
pre-eclampsia, of experiencing a shoulder dystocia or a
postpartum hemorrhage and are more likely to deliver
by caesarean section [8]. Maternal diabetes is also a
known condition associated with stillbirths [9], 10 % of
which are attributable to non-communicable diseases
[10]. In the long term, GDM affected women and their
newborns are more prone to developing manifest dia-
betes mellitus [8, 11].
Although guidelines from high income settings on
GDM screening and management are available and
freely downloadable from the internet [12, 13], there is a
lack of knowledge about the extent to which guidelines
developed in high income settings are appropriate for
use in less developed countries, where resources are
scarce and access to care is limited [14].
The objective of our survey was therefore to identify
existing challenges for first line health care providers in
LLMIC regarding the detection and management of
GDM and to use the findings to inform leaders of pro-
fessional associations and policy makers involved in ma-
ternal and newborn health programmes. By identifying
these challenges, the study aimed to contribute to the
development of strategies for improving detection and
management of GDM.
Methods
We conducted a cross-sectional survey in 40 out of the
56 LLMIC in Africa, South-Asia and Latin- America eli-
gible for World Bank funding [15] to assess clinical prac-
tices used in detection and management of GDM and to
explore existing challenges. To identify key informants,
such as representatives of national professional societies
or leading gynecologists in low and lower middle income
settings we contacted members of our institutional net-
works in the respective countries. Identified key contactswere invited to participate in the survey. We then used
snowball sampling, asking these key contacts to identify
additional health care professionals in their respective
countries, including gynecologists, endocrinologists and
medical doctors working in the public and/or private
sector at all levels of the health care system and involved
in providing care to pregnant women and in screening
and management of GDM. The survey tool, a self-
administered semi-structured questionnaire containing a
mixture of multiple choice and open-ended questions,
was available in four languages (English, French, Spanish
or Portuguese) and was sent out by email to a total of
182 gynecologists, endocrinologists and medical doctors
in 40 LLMIC. Questionnaires were not sent to countries
that were either affected by crisis or war (5) or where we
failed to identify a key informant (11). Returning the
completed questionnaire was considered as consent to
participate in the study. A total of 77 respondents from
27 LLMIC returned the questionnaires and 67 respon-
dents from 26 countries answered the open ended ques-
tions on challenges they encountered with GDM
screening and management (Fig. 1). All data was han-
dled anonymously with profession and country as sole
identifiers and double entered into SPSS Version 21. All
open responses were copied into an excel file and the-
matically analyzed. After sorting and grouping the data,
eight thematic areas were identified. These included
guidelines, human resources, access, costs, availability of
services, of equipment and drugs, patient and commu-
nity factors as well as collaboration and communication.
Ethical approval for the study was granted by the Institu-
tional Review Board of the Institute of Tropical Medicine,
Antwerp, Belgium.Results
Various challenges regarding GDM detection and man-
agement were highlighted by 67 survey respondents, in-
cluding 59 gynecologists, five endocrinologists and three
general practitioners from 26 LLMIC. 61.2 % of the re-
spondents providing information on challenges were
from Africa, 37.3 % from South-Asia and 1.5 % from
Latin-America. 22.4 % of them were representatives at
national level, 49.3 % were working in the public sector,
23.9 % in private facilities (including faith-based and
non-governmental) and 4.5 % in both the public and pri-
vate sector.Guidelines
Several respondents highlighted problems concerning
guidelines in their countries. Some informants com-
plained that no standard protocols were available in their
settings. In countries where protocols were available,
these were sometimes not adequately disseminated, not
Fig. 1 Map depicting location of respondents
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providers (Table 1a).
Human resources
Regarding health care providers’ knowledge, survey re-
spondents indicated that providers lack the required
knowledge to screen for GDM and/or manage affected
patients. In many settings, no particular training in
GDM is provided, partly due to a lack of financial re-
sources. Providers complained that updates are not
available, which, coupled with limited internet access, re-
stricts their ability to obtain latest practice updates.
Many providers also indicated that general awareness of
GDM is low due to lack of knowledge regarding GDM
prevalence in their countries. One respondent stated
that interest in GDM is limited, even among specialists.
Respondents also mentioned that counselling by pro-
viders is inadequate. One informant highlighted a lack of
midwifes trained to provide counselling on GDM risks
in the communities.
Respondents stated that despite the call for universal
screening, some health care providers only screen
women with risk factors. Others do not even screen
when risk factors are present. Furthermore, is was re-
ported that few lab technicians know about specific tests
to detect GDM, such as the O’Sullivan glucose challenge
test (Table 1b).
Access
Access to care was mentioned as a challenge for screen-
ing and management. In countries, in which antenatal
care (ANC) coverage is low, some patients attend ANCeither late in pregnancy or deliver without having
attended any ANC consultation. In some settings, only
15 % of women attend public facilities. According to one
respondent this can pose problems, particularly because
harmonization of practices with the often unregulated
private sector is challenging.
Transport can be an obstacle, especially for women re-
ceiving insulin. Difficulties in ensuring regular monitor-
ing and follow-up of patients were highlighted by
various respondents as major challenges. The complexity
of the care system and the need to consult different
health care providers also makes access for pregnant
women difficult (Table 1c).
Costs
Financial access to care and the ability to pay for transport
and treatment were identified as major barriers to ad-
equate management of GDM. Costs are not only related
to accessing health care facilities, but include expenses for
specific screening tests, for repeat testing and for other in-
vestigations such as obstetric ultrasound scans. Patients
diagnosed with GDM often face additional costs of pur-
chasing testing equipment such as glucometers and
testing-strips for self-monitoring their blood glucose, as
well as for medication and hospitalization. Respondents
highlighted that some examinations, such as the
O’Sullivan test or obstetric ultrasound scans, are only
performed in private laboratories or practices. In
addition, costs related to diet play an equally important
role. In many low resource settings women are accus-
tomed to a traditional carbohydrate rich diet. Proteins,
fruits and vegetables, all ingredients of a balanced
Table 1 Reported challenges with GDM screening and management grouped by thematic area
a. Guidelines b. Human resources c. Access &
follow-up
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adhering to such a diet is difficult, especially for poorer
women with GDM (Table 1d).
Availability
Services
Service availability plays an important role in the detec-
tion and management of GDM. In addition to limited
availability of screening services in public facilities of dif-
ferent levels, informants indicated that laboratories often
pose a challenge. Technical problems were mentioned,
as well as a shortage of laboratories in the public sector.
Respondents stated that laboratories do not provide ser-
vices 24/7 and certain tests, such as the O’Sullivan test,
the oral glucose tolerance test (OGTT) and the glycosyl-
ated hemoglobin analysis (HbA1C) are not always done.
One respondent mentioned that laboratories performing
such specific tests are often located in urban areas. Due
to difficulties getting these tests done in the public sector,
women have to turn to private facilities. Furthermore,
there is a shortage of specific health care providers, such
as endocrinologists and nutritionists, to provide expert ad-
vice in many low income settings (Table 1e).
Equipment and drugs
When it comes to equipment, a shortage of laboratory
supplies and screening reagents including anhydrous
glucose, urine dipsticks and capillary test-strips was
mentioned. The regular calibration of glucometers against
laboratory standards was considered a technical challenge
for ensuring adequate management.
Drug availability was identified as yet another constraint,
particularly availability of insulin analogues. Difficulties for
patients buying insulin (market availability as well as
costs), and challenges for health care providers adminis-
tering insulin during labour without having infusion
pumps at their disposal, were also identified as obstacles
(Table 1f).
Patient/community factors
Survey respondents indicated that patient and commu-
nity related factors are key barriers. They reported a lack
of awareness of diabetes in pregnancy, ignorance of the
potential risks and false perceptions regarding GDM.
Convincing patients of the need to commence and ad-
here to a specific diet, to check glucose levels regularly
and to attend regular follow-up visits were listed as sub-
stantial challenges for health care providers. These chal-
lenges were compounded in settings in which the
husband’s approval is essential to women’s ability to seek
healthcare. Furthermore, adherence to a diet, treatment
and regular monitoring may interfere with the domestic
responsibilities of affected women.Discontinuation of diet and treatment were also men-
tioned and partly explained by lack of motivation. Re-
spondents reported a reluctance to comply with insulin
management due to fears related to the administration
of insulin and to its side effects. Regarding physical exer-
cise, limited options and the unavailability of dedicated lo-
cations (e.g. gyms) where women can exercise often restrict
recommendations to brisk walking. Self-monitoring of
blood glucose was pointed out as a challenge by several re-
spondents. Illiteracy and the difficulty of acquiring a private
glucometer were considered reasons for women’s inability
to self-monitor glucose.
Women often do not comply with the recommended
diet during pregnancy and discontinue glucose monitor-
ing, their diet and exercise after delivery. Many women
would not return for a re-test post-partum, despite having
been advised to do so. Other reported patient related fac-
tors regarding screening include vomiting after glucose in-
gestion, particularly when given in the first trimester. It
was also highlighted that some women are not willing to
wait for two hours to get their blood tested (Table 1g).
Collaboration and coordination
Inadequate collaboration between different specialists
might negatively impact efficient management of GDM,
particularly in settings in which additional logistical hur-
dles exist. Respondents mentioned that collaboration be-
tween different professionals is often difficult. Similarly,
the lack of multidisciplinary teams was reported. Good
coordination is essential, as patients have to circulate be-
tween different services and might even have to consult
various specialists. Informants mentioned delays in care
because patients have to undergo requested tests at the
laboratory and then have to revisit the doctor with the
results. In case of delays during this process, women are
subject to extensive waiting times and this might increase
the risk of drop outs. Furthermore, time lags between taking
blood and its final analysis in the laboratory could cause
measurement errors. Sometimes services are overcrowded,
which negatively impacts on health care providers’ capacity
to screen patients. Similarly, lack of sufficient patient infor-
mation in terms of where to go for screening and follow-up
might cause further delays and result in loss to follow-up
(Table 1h).
Limitations
The collected challenges present individual views of key
informants, mainly of obstetricians from the different
countries. As such, these challenges are indicative of
problems in individual health care services and might
therefore not be generalizable. However, the similarity of
the challenges reported by various key respondents
would suggest that comparable problems are encoun-
tered in several low and lower-middle income countries.
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care providers and did not include the views of patients
represents another limitation of this study.
Discussion
Our study reveals that providers in LLMIC face various
challenges related to screening and management of
GDM. General availability of guidelines and provision of
specific training on GDM is one of the repeatedly men-
tioned obstacles. Some of these problems have been pre-
sented in a recent study conducted in Tanzania, where
guidelines on diabetes were only available in 13 % of all
facilities and only a third of doctors felt comfortable
with the management of diabetes [16].
According to our findings, costs associated with GDM
screening and management represent one of the major
reasons for which GDM is not adequately addressed in
LLMIC. Financial constraints have also been highlighted
in a study on diabetes care in Tunisia, where costs re-
lated to travel, medication and testing presented serious
constraints [17]. Costs of detection and management of
GDM are not necessarily part of the packages of care
that are offered to pregnant women and these often
exclude specific laboratory tests, additional ultrasound
investigations or equipment for self-testing such as gluc-
ometers and test strips. Furthermore, expenses related to
hospitalization in LLMIC have shown to have detrimen-
tal effects on families, as these not only involve direct
but also substantial indirect costs [18].
However, costs are only one of many factors that ham-
per adequate management of GDM in LLMIC. Even if
costs could be reduced, issues such as compliance and
motivation of patients to follow recommendations would
persist. Studies have shown that patients who are in-
volved in decision making have better health outcomes
[19]. But this would require that patients are informed
about their condition. Our findings reveal a lack of
knowledge about GDM and its associated risks, as well
as false beliefs that may threaten the benefits that can be
expected from screening [20]. Good communication be-
tween patients and providers, as well as between providers
themselves, could ensure that patients feel well informed
and, as a consequence, comply with medical advice.
The role of community health workers in diabetes care
is not a new concept and their potentially beneficial role
in coaching can result in improved compliance and bet-
ter outcomes [21, 22]. Nevertheless, their role in provid-
ing supportive care for GDM affected patients remains
to be assessed. To reduce costs and improve monitoring,
some innovative ideas have been reported from Kenya,
where former GDM patients trained women in self-
monitoring of their blood glucose levels and healthcare
providers offered backup management support in the
form of weekly mobile telephone follow-ups [23].Several challenges highlighted in our study are related
to resources both in terms of staff requirements and re-
garding equipment and drugs. Solving these problems
would require improved overall health care organization
that better integrates non-communicable diseases into
the existing packages of care. In many LLMIC, maternal
and perinatal mortality is still high and there is a persist-
ing need to improve access to and provision of emer-
gency obstetric and neonatal care. However, the parallel
emergence of non-communicable diseases affecting ma-
ternal and newborn health in these settings will grad-
ually place a double burden on existing health systems
[24]. To increase awareness and improve universal de-
tection of GDM in pregnancy, delegation of tasks to
mid-or lower level health care providers could represent
one potential solution and has already been initiated in
India where, according to the latest national guidelines
GDM screening now takes place at the first level of care
[25]. Required health system related adjustments of
GDM detection and management practices target
clinical information systems, decision support through
evidence based guidelines, redesign of health care
delivery systems, self-management support and the
use of community resources and are in line with the
elements reflected in the chronic care model concep-
tualized by Wagner [26].
The long list of challenges regarding patient and com-
munity related factors mentioned by care givers indi-
cates a need for critical reflection on the reasons for
which health care providers face such difficulties in
managing patients with GDM in their settings. Are we
using patient related obstacles as a scapegoat for our
failure to provide adequate care and follow-up? To en-
able patients to follow medical advice, we need to invest
more in sensitizing women and their families about
GDM and to tailor our interventions and recommenda-
tions to their needs and potential - not vice versa. Uni-
form GDM guidelines are an important first step but
more needs to be done to avoid dissatisfaction on the
part of both providers and clients. Otherwise the ques-
tion asked by one respondent “Why screen if we cannot
follow-up and manage? Only to put pressure on the
woman or on the care team?” will not be satisfactorily
addressed.Conclusion
Providers from LLMIC face various challenges related to
screening for and management of GDM. Policy makers
need to address these challenges by strengthening their
respective health care system as a whole and by ensuring
that non-communicable diseases are better integrated
into existing packages of free or subsidized maternal
health care.
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